AnaptysBio, Inc. (LON:0HFQ)
23.26
+0.21 (0.91%)
At close: Sep 12, 2025
AnaptysBio Revenue
AnaptysBio had revenue of $22.26M USD in the quarter ending June 30, 2025, with 102.93% growth. This brings the company's revenue in the last twelve months to $123.16M, up 304.17% year-over-year. In the year 2024, AnaptysBio had annual revenue of $91.28M with 432.03% growth.
Revenue (ttm)
$123.16M
Revenue Growth
+304.17%
P/S Ratio
4.52
Revenue / Employee
$905.62K
Employees
136
Market Cap
405.96M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 91.28M | 74.12M | 432.03% |
Dec 31, 2023 | 17.16M | 6.87M | 66.78% |
Dec 31, 2022 | 10.29M | -52.89M | -83.72% |
Dec 31, 2021 | 63.18M | -11.83M | -15.77% |
Dec 31, 2020 | 75.00M | 67.00M | 837.50% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
HSBC Holdings | 41.03B |
Shell | 198.54B |
Unilever | 51.24B |
Rolls-Royce Holdings | 19.54B |
British American Tobacco p.l.c. | 25.60B |
Rio Tinto Group | 39.22B |
BP p.l.c. | 134.89B |